Sorrow for the Loss of Dr. Sousa

On behalf of the Latin American Society of Interventional Cardiology (SOLACI), We extend our deepest condolences for the departure of our esteemed professor Doctor José Eduardo Morais Rego Sousa, renowned hemodynamist and interventional cardiologist, former Director of the Institute of Cardiology Dante Pazzanese, the Brazilian Society of Interventional Cardiology (SBHCI) and a pillar in the creation of our society, which he successfully chaired between 1996 and 1998. 

Doctor Sousa is known worldwide for diverse outstanding medical innovations, such as the first stenting experiences with conventional stents in humans, a technique he would later perfect with the use of drug eluting stents.  

From SOLACI we join his family and friends in this time of grief, as well as several generations of disciples who learnt this cardiology subspecialty under his wing, following the rigorous example of our unforgettable Doctor Eduardo. May he rest in peace. 

Message from Dr. Aníbal Damonte, President of SOLACI

Message from Dr. Hugo Londero, Former SOLACI President

Message from Dr. Alberto Suárez Nitola, Former SOLACI President

Message from Dr. Jorge Belardi, Former SOLACI President


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SOLACI Wishes You Happy Holidays

From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....